|
|||||
|
|
Evaluation of programmed death ligand 1 expression in cytology to determine eligibility for immune checkpoint inhibitor therapy in patients with head and neck squamous cell carcinoma |
|
| Authors: | Zhonghua Liu MD PhD Michelle Williams MD John Stewart MD PhD Bonnie S Glisson MD Clifton Fuller MD PhD Sinchita Roy-Chowdhuri MD PhD |
| Institution: | 1. Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas;2. Thoracic/Head and Neck Medical Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, Texas;3. Radiation Oncology Department, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| Abstract: | |
| Keywords: | cell block fine-needle aspiration head and neck immunostaining programmed death ligand 1 (PD-L1) squamous cell carcinoma |